查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829402

2025年全球製氧機市場報告

Artificial Lung Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，氧合器市場規模迅速擴張，從2024年的23.1億美元成長到2025年的25.8億美元，複合年成長率為11.6%。預測期內的成長可歸因於醫療保健專業人士意識的提升、市場滲透率的提高、居家照護應用的增加、醫療旅遊業的蓬勃發展以及醫療基礎設施的改善。

預計未來幾年人工肺市場規模將快速成長，到2029年將達到39.1億美元，複合年成長率為11.0%。預測期內的成長可歸因於呼吸系統疾病盛行率的上升、醫療設施的改善、微創手術的接受度不斷提高、患者生活品質的提高以及慢性阻塞性肺病盛行率的上升。預測期內的主要趨勢包括無線技術的整合、人工智慧 (AI) 的整合、基因組學和醫療技術的進步，以及更小巧便攜的人工肺的開發。

氧合器是醫療設備，透過給予血液氧氣並去除二氧化碳來取代自然肺的功能。它通常用於嚴重呼吸衰竭的患者，或在手術過程中必須暫時停止心肺功能的患者。該技術旨在支持或取代肺功能，提高患者的存活率和嚴重患者的康復率。

氧合器的主要類型包括單滾輪泵心肺機、雙滾輪泵心肺機、鼓泡式氧合器和膜式氧合器。單一滾輪泵心肺機在心肺體外迴圈手術中使用單一滾輪泵來循環血液。這類機器用於心血管手術、肺移植、急性呼吸衰竭治療和其他醫療程序，滿足各種終端使用者的需求，包括醫院、急診中心和醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

氧合器研究報告是商業研究公司最新報告系列的一部分，該系列提供氧合器市場統計數據，包括全球市場規模、區域佔有率、氧合器市場佔有率的競爭對手、詳細的氧合器市場細分、市場趨勢以及氧合器行業的商機。這份氧合器市場研究報告對產業現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整展望。

預測的五年成長率為11.0%，較我們先前對該市場的預測略有下降0.9%。下降的主要原因是美國與其他國家之間的關稅影響。由於德國微孔膜氧合器和瑞典肝素塗層迴路供應中斷，導致體外膜氧合器 (ECMO) 和呼吸支持治療延遲，這一影響將對美國產生直接影響。

由於呼吸系統疾病的日益流行，人工肺市場預計將會成長。這種成長受到空氣污染加劇、氣候變遷和生活方式改變等因素的影響，給公眾健康帶來了沉重的負擔。人工肺部透過提供氧氣、去除血液中的二氧化碳以及支持或替代受損的肺功能，在治療呼吸系統疾病方面發揮關鍵作用。例如，根據澳洲健康與福利研究所 2024 年 6 月的報告，估計澳洲約有 850 萬人（佔總人口的 34%）患有慢性呼吸系統疾病。其中包括 280 萬人患有氣喘（佔總人口的 11%）和 638,000 人慢性阻塞性肺病(COPD)（佔總人口的 2.5%）。因此，呼吸系統疾病的日益普及是人工肺部市場擴張的主要驅動力。

氧合器市場涵蓋體外膜氧合 (ECMO)、靜脈膜氧合 (IVOX)、生物人工肺和微流體氧合器的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球氧合器：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球製氧機市場：成長率分析
  • 全球製氧機市場表現：規模與成長，2019-2024
  • 全球製氧機市場預測：規模與成長，2024-2029年，2034年
  • 全球氧合器：總目標市場（TAM）

第6章 市場細分

  • 全球製氧機市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 單滾輪泵心肺機
  • 雙滾輪泵心肺機
  • 氣泡氧合器
  • 膜式氧合器
  • 全球製氧機市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心血管手術
  • 肺移植手術
  • 急性呼吸衰竭的治療
  • 其他用途
  • 全球製氧機市場（依最終用戶分類）：2019-2024 年、2024-2029 年、2034 年業績及預測
  • 醫院
  • 急診中心
  • 其他最終用戶
  • 全球氧合器市場：單滾輪幫浦心肺氧合器的細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 可攜式單滾輪泵體外循環機
  • 固定式單滾輪幫浦體外循環機
  • 全球氧合器市場：雙滾泵心肺氧合器的細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 可攜式雙滾泵體外循環機
  • 固定式雙滾輪幫浦體外循環機
  • 全球氧合器市場：按氣泡氧合器類型、性能和預測進行細分，2019-2024 年、2024-2029 年、2034 年
  • 一次使用氣泡氧合器
  • 可重複使用的氣泡氧合器
  • 全球氧合器市場：膜氧合器的細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 氧合膜氧合器
  • 二氧化碳脫除膜氧合器

第7章 區域和國家分析

  • 全球製氧機市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球製氧機市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工肺市場：競爭格局
  • 氧合肺市場：公司簡介
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • TransMedics Group Inc.
  • Braile Biomedica Ltd.
  • Xenios AG
  • MC3 Cardiopulmonary Inc.
  • Lung Biotechnology PBC
  • Breethe Inc.
  • Levitronix LLC
  • Medos Medizintechnik AG
  • ALung Technologies Inc.
  • McGowan Institute for Regenerative Medicine
  • Hemovent GmbH
  • Novalung GmbH
  • Haemair Ltd.
  • MedArray Inc.
  • Vivonics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年氧合器市場：提供新機會的國家
  • 2029 年氧合器市場：細分市場帶來新機會
  • 2029年制氧機市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29436u

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.58 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to growing awareness among healthcare professionals, increasing market penetration, increasing applications in-home care setting, the rise in medical tourism, and improvements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, improvements in healthcare facilities, rising acceptance of minimally invasive procedures, enhanced patient quality of life, and rising prevalence of chronic obstructive pulmonary diseases. Major trends in the forecast period include the integration of wireless technology, artificial intelligence (AI) integration, advances in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The forecast of 11.0% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply disruptions for microporous oxygenator membranes from Germany and heparin-coated circuits from Sweden, delaying extracorporeal membrane oxygenation (ECMO) and respiratory support treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Major companies in the artificial lung market are focusing on developing innovative solutions, such as remote monitoring and control systems, to gain a competitive edge. These systems enable healthcare professionals to monitor patients' vital signs and adjust ventilation settings remotely, without needing to be physically present at the bedside. This approach helps reduce the risk of infection and improves patient safety during treatment. For example, in August 2022, Teltonika Telemedic, a U.S.-based electronics manufacturer, made significant strides in developing its artificial lung ventilator, TELTOMED. The company secured an exclusive patent for the secure remote transmission and control of its ventilator, enhancing the security and reliability of patient data communication-an essential feature for modern medical devices.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
  • 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
  • 3) By End-Users: Hospital; Emergency Center; Other End-users
  • Subsegments:
  • 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
  • 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
  • 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
  • 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
  • Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.; TransMedics Group Inc.; Braile Biomedica Ltd.; Xenios AG; MC3 Cardiopulmonary Inc.; Lung Biotechnology PBC; Breethe Inc.; Levitronix LLC; Medos Medizintechnik AG; ALung Technologies Inc.; McGowan Institute for Regenerative Medicine; Hemovent GmbH; Novalung GmbH; Haemair Ltd.; MedArray Inc.; Vivonics Inc.; Extracorporeal Life Support (ECLS) Lab
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Lung Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Lung Market Growth Rate Analysis
  • 5.4. Global Artificial Lung Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Lung Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Lung Total Addressable Market (TAM)

6. Artificial Lung Market Segmentation

  • 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Roller Pump Heart Lung Machines
  • Double Roller Pump Heart Lungs Machines
  • Bubble Artificial Lung
  • Membrane Artificial Lung
  • 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Other Applications
  • 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Emergency Center
  • Other End-user
  • 6.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Single Roller Pump Heart Lung Machines
  • Stationary Single Roller Pump Heart Lung Machines
  • 6.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Double Roller Pump Heart Lung Machines
  • Stationary Double Roller Pump Heart Lung Machines
  • 6.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Bubble Artificial Lung
  • Reusable Bubble Artificial Lung
  • 6.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oxygenator Membrane Artificial Lung
  • Carbon Dioxide Removal Membrane Artificial Lung

7. Artificial Lung Market Regional And Country Analysis

  • 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Lung Market

  • 8.1. Asia-Pacific Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Lung Market

  • 9.1. China Artificial Lung Market Overview
  • 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Lung Market

  • 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Lung Market

  • 11.1. Japan Artificial Lung Market Overview
  • 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Lung Market

  • 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Lung Market

  • 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Lung Market

  • 14.1. South Korea Artificial Lung Market Overview
  • 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Lung Market

  • 15.1. Western Europe Artificial Lung Market Overview
  • 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Lung Market

  • 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Lung Market

  • 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Lung Market

  • 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Lung Market

  • 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Lung Market

  • 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Lung Market

  • 21.1. Eastern Europe Artificial Lung Market Overview
  • 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Lung Market

  • 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Lung Market

  • 23.1. North America Artificial Lung Market Overview
  • 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Lung Market

  • 24.1. USA Artificial Lung Market Overview
  • 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Lung Market

  • 25.1. Canada Artificial Lung Market Overview
  • 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Lung Market

  • 26.1. South America Artificial Lung Market Overview
  • 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Lung Market

  • 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Lung Market

  • 28.1. Middle East Artificial Lung Market Overview
  • 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Lung Market

  • 29.1. Africa Artificial Lung Market Overview
  • 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Lung Market Competitive Landscape
  • 30.2. Artificial Lung Market Company Profiles
    • 30.2.1. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Lung Market Other Major And Innovative Companies

  • 31.1. TransMedics Group Inc.
  • 31.2. Braile Biomedica Ltd.
  • 31.3. Xenios AG
  • 31.4. MC3 Cardiopulmonary Inc.
  • 31.5. Lung Biotechnology PBC
  • 31.6. Breethe Inc.
  • 31.7. Levitronix LLC
  • 31.8. Medos Medizintechnik AG
  • 31.9. ALung Technologies Inc.
  • 31.10. McGowan Institute for Regenerative Medicine
  • 31.11. Hemovent GmbH
  • 31.12. Novalung GmbH
  • 31.13. Haemair Ltd.
  • 31.14. MedArray Inc.
  • 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Lung Market

34. Recent Developments In The Artificial Lung Market

35. Artificial Lung Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Lung Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Lung Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Lung Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer